Results of IHC and MSI analysis in tissues of <i>MSH3</i> mutation patients.

For MSH3 IHC, “3+” indicates strong staining, “2+” indicates intermediate staining, “1+” indicates week staining, and “0” indicates no staining. For MSI profiles, it includes MSI data for five consensus National Cancer Institute (NCI) microsatellite markers (two mono-A repeats, BAT25 and BAT26, and three dinucleotide repeats, D2S123 through D17S250), two additional dinucleotide (D) markers (D18S69 and D18S64), and seven EMAST markers (MYCL1 through D8S321). For MSI data, “-” indicates the absence of the mutation, and “+” indicates the presence of the mutation. For MSI using the NCI panel (NCI), S indicates MSS. For MSI using the NCI panel and two additional dinucleotide markers (NCI and D status), S indicates MSS, and L indicates MSI-L. For EMAST status, E indicates EMAST positive, and non-E indicates EMAST negative. Results of IHC and MSI analysis in tissues of MSH3 mutation patients.